Radiant Acids & Alkalies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 19.53%
(FY 2023)
- Ebitda 34.37%
(FY 2023)
- Net Worth -1.02%
(FY 2023)
- Total Assets -0.72%
(FY 2023)
About Radiant Acids & Alkalies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Mittal, Anshul Mittal, and Sudhir Bansal serve as directors at the Company.
- CIN/LLPIN
U45400DL2008PLC174494
- Company No.
174494
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Radiant Acids & Alkalies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Mittal  | Director | 25-Feb-2008 | Current |
| Anshul Mittal | Additional Director | 15-Feb-2012 | Current |
| Sudhir Bansal | Director | 25-Feb-2008 | Current |
Financial Performance of Radiant Acids & Alkalies.
Radiant Acids & Alkalies Limited., for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 19.53% increase in profit. The company's net worth dipped by a decrease of 1.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radiant Acids & Alkalies?
In 2023, Radiant Acids & Alkalies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhawani Acids & Alkalies Private LimitedActive 29 years 5 monthsAshok Mittal and Anshul Mittal are mutual person
- Kamaan Healthcare Private LimitedActive 3 years 9 months
Ashok Mittal and Anshul Mittal are mutual person
- Redivv Creations Private LimitedActive 3 years 4 months
Ashok Mittal and Anshul Mittal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Radiant Acids & Alkalies?
Unlock and access historical data on people associated with Radiant Acids & Alkalies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radiant Acids & Alkalies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radiant Acids & Alkalies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
